Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 491

2.

Vaccination-induced HI antibody response to intraepidemic influenza A(H3N2) virus variants of the 1996-1997 epidemic season.

Pyhälä R, Ikonen N, Santanen R, Haanpää M, Visakorpi R, Jäppinen P, Valle M.

J Med Virol. 2001 Nov;65(3):584-9.

PMID:
11596097
3.
4.

Live attenuated influenza vaccine induces cross-reactive antibody responses in children against an a/Fujian/411/2002-like H3N2 antigenic variant strain.

Mendelman PM, Rappaport R, Cho I, Block S, Gruber W, August M, Dawson D, Cordova J, Kemble G, Mahmood K, Palladino G, Lee MS, Razmpour A, Stoddard J, Forrest BD.

Pediatr Infect Dis J. 2004 Nov;23(11):1053-5.

PMID:
15545863
5.

Cross-reactivity of influenza A (H3N2) hemagglutination-inhibition antibodies induced by an inactivated influenza vaccine.

Kojimahara N, Maeda A, Kase T, Yamaguchi N.

Vaccine. 2006 Aug 14;24(33-34):5966-9. Epub 2006 May 26.

PMID:
16777274
6.

[The 2002/2003 influenza season in the Netherlands and the vaccine composition for the 2003/2004 season].

de Jong JC, Rimmelzwaan GF, Bartelds AI, Wilbrink B, Fouchier RA, Osterhaus AD.

Ned Tijdschr Geneeskd. 2003 Oct 4;147(40):1971-5. Dutch.

PMID:
14574782
7.

Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?

Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.

Pediatrics. 2006 Sep;118(3):e570-8.

PMID:
16950948
8.

Cross-reaction but no avidity change of the serum antibody response after influenza vaccination.

Brokstad KA, Cox RJ, Major D, Wood JM, Haaheim LR.

Vaccine. 1995 Nov;13(16):1522-8.

PMID:
8578836
9.
10.
11.

Intanza(®) 15 mcg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses.

Ansaldi F, Canepa P, Ceravolo A, Valle L, de Florentiis D, Oomen R, Vogel FR, Denis M, Samson SI, Icardi G.

Vaccine. 2012 Apr 16;30(18):2908-13. doi: 10.1016/j.vaccine.2012.02.003. Epub 2012 Feb 15.

PMID:
22342501
12.

Further protection against antigenic drift of influenza virus in a ferret model by DNA vaccination.

Donnelly JJ, Friedman A, Ulmer JB, Liu MA.

Vaccine. 1997 Jun;15(8):865-8.

PMID:
9234535
13.

Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.

Skowronski DM, Masaro C, Kwindt TL, Mak A, Petric M, Li Y, Sebastian R, Chong M, Tam T, De Serres G.

Vaccine. 2007 Apr 12;25(15):2842-51. Epub 2006 Oct 16.

PMID:
17081662
15.

An influenza A/H3 outbreak during the 2004/2005 winter in elderly vaccinated people living in a nursing home.

Iorio AM, Neri M, Lepri E, Camilloni B, Basileo M, Sigismondi N, Fabiani C, Calzoletti L, Puzelli S, Donatelli I.

Vaccine. 2006 Nov 10;24(44-46):6615-9. Epub 2006 Jun 5.

PMID:
16828941
16.

Efficacy of influenza vaccination in adult liver transplant recipients.

Soesman NM, Rimmelzwaan GF, Nieuwkoop NJ, Beyer WE, Tilanus HW, Kemmeren MH, Metselaar HJ, de Man RA, Osterhaus AD.

J Med Virol. 2000 May;61(1):85-93.

PMID:
10745238
17.

Evaluation of influenza virus A/H3N2 and B vaccines on the basis of cross-reactivity of postvaccination human serum antibodies against influenza viruses A/H3N2 and B isolated in MDCK cells and embryonated hen eggs.

Kishida N, Fujisaki S, Yokoyama M, Sato H, Saito R, Ikematsu H, Xu H, Takashita E, Tashiro M, Takao S, Yano T, Suga T, Kawakami C, Yamamoto M, Kajiyama K, Saito H, Shimada S, Watanabe S, Aoki S, Taira K, Kon M, Lin JH, Odagiri T.

Clin Vaccine Immunol. 2012 Jun;19(6):897-908. doi: 10.1128/CVI.05726-11. Epub 2012 Apr 4.

19.

Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.

Skowronski DM, De Serres G, Dickinson J, Petric M, Mak A, Fonseca K, Kwindt TL, Chan T, Bastien N, Charest H, Li Y.

J Infect Dis. 2009 Jan 15;199(2):168-79. doi: 10.1086/595862.

PMID:
19086914
20.

An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine.

Del Giudice G, Hilbert AK, Bugarini R, Minutello A, Popova O, Toneatto D, Schoendorf I, Borkowski A, Rappuoli R, Podda A.

Vaccine. 2006 Apr 12;24(16):3063-5. Epub 2006 Jan 19.

PMID:
16464520

Supplemental Content

Support Center